Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin for neonatal mortality in Burkina Faso
NCT03682653Phase 4Completed
- Sponsor
- University of California, San Francisco
- Start
- Apr 2019
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of azithromycin, sponsored by University of California, San Francisco. Started Apr 2019; status: completed.
02
Drugs
azithromycin
Beyond the preview
Go deeper on NCT03682653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03682653.